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Abstract
The effects of two fusion inhibitors on the lipid polymorphism of N-methylated dioleoylphosphatidylethanolamine were
studied using temperature-resolved, small-angle X-ray diffraction. The inhibitory role of the tri-peptide carbobenzoxy-D-
phenylalanine-L-phenylalanine-glycine and the lipid 1-lauroyl-2-hydroxy-sn-glycero-3-phosphocholine in the fusion path-
way was studied, using the non-lamellar phase behaviour of the lipid as a model. We used p15EK, the N-terminal region of
gp41 from feline leukaemia virus as promoter of membrane fusion, and measured the structural parameters of each
observed lipid phase as a function of temperature. The fusion inhibitors were found to impede the expression of negative
curvature of lipid monolayers even in the presence of fusion peptide. The results of this study are interpreted in relation to
models of the membrane fusion mechanism. ß 2002 Published by Elsevier Science B.V.
Keywords: Time resolved X-ray di¡raction; Small angle X-ray di¡raction; Small angle X-ray scattering; Biomembrane fusion; Inhibitor;
Lamellar phase; Cubic phase; Hexagonal phase
1. Introduction
Enveloped virus particles require membrane fusion
in order to introduce their infective nuclear material
into a host cell [1]. Each virus employs specialised,
extra-membranous glycoproteins that catalyse the fu-
sion process. These so-called ‘fusion proteins’ pro-
mote the merging of two originally distinct mem-
branes into one. Research has shown that peptides
derived from the N-terminus of fusion proteins, ex-
hibit similar membrane fusion activities. We have
previously reported that the fusion peptide from fe-
line leukaemia virus (FeLV), p15EK, destabilises the
LK phase and promotes the formation of non-bilayer
structures by increasing negative curvature strain
[2,3].
Part of the fusion process involves the bending of
individual lea£ets of both the viral and cell mem-
brane into more tightly curved structures than nor-
mally encountered [4]. Current theory states that
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Abbreviations: CBZ-D-FFG, carbobenzoxy-D-phenylalanine-
L-phenylalanine-glycine; dH, lattice repeat distance (hexagonal
phase phospholipid); dL, lattice repeat distance (lamellar phase
phospholipid); dQ, lattice repeat distance (cubic phase phospho-
lipid) ; DOPE-Me, N-methylated dioleoylphosphatidylethanol-
amine; EDTA, ethylenediaminetetraacetic acid; FeLV, feline leu-
kaemia virus; LPC, 1-lauroyl-2-hydroxy-sn-glycero-3-phospho-
choline; MLV, multilamellar vesicle ; p15EK, fusion peptide
from spike protein p15E of FeLV; PIPES, 1,4-piperazinedietha-
nesulfonic acid; q, 2Z/d ; SAXS, small-angle X-ray scattering; TH,
temperature at which hexagonal phase is ¢rst observed; TQ, tem-
perature at which cubic phase is ¢rst observed
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monolayer curvature leads to the formation of non-
lamellar structures prior to the formation of the fu-
sion pore [5]. Each outer membrane lea£et exhibits
negative curvature whilst each inner membrane leaf-
let exhibits positive curvature during the formation
of highly curved intermediates [6,7]. This theory can
be tested by altering the lipid composition or by in-
cluding asymmetrical agents, such as peptides, lyso-
lipids or other molecules that have contrasting e¡ects
on membrane curvature strain [4,8,9], and observing
changes in the phase behaviour of the lipid.
We report on the e¡ects of the two fusion inhib-
itors, one protein based, carbobenzoxy-D-phenylala-
nine-L-phenylalanine-glycine (CBZ-D-FFG), and one
phospholipid based, 1-lauroyl-2-hydroxy-sn-glycero-
3-phosphocholine (LPC) on the lipid phase behav-
iour of multilamellar vesicles (MLVs) composed
of N-methylated dioleoylphosphatidylethanolamine
(DOPE-Me).
CBZ-D-FFG is a hydrophobic tripeptide that in-
hibits the fusion process in a dose-dependent manner
[10]. Multinuclear resonance spectroscopy and calo-
rimetric analysis suggest that its interaction with
phospholipid membranes account for its mechanism
of action. It is thought that CBZ-D-FFG resides
within the membrane interface and prevents the for-
mation of highly curved surfaces [11,12]. CBZ-D-
FFG raises the lamellar-to-hexagonal phase transi-
tion temperature [13] indicating a reluctance of this
peptide to be associated with lipids that exhibit neg-
ative curvature at lower temperatures.
The detergent LPC forms oil-in-water micellar ag-
gregates when in an excess water condition above its
critical micelle concentration. Its large hydrated
headgroup and relatively short hydrocarbon chain
give the molecule an inverted cone shape. This shape
is thought to reduce negative curvature strain of the
outer membrane lea£et during the initial stages of the
fusion event [14^16].
Lipid mesomorphism was measured by tempera-
ture-resolved X-ray di¡raction, a quantitatively and
qualitatively direct method of characterising lipid
phase transitions. Real-time small-angle X-ray scat-
tering (SAXS) images were recorded of pure lipid
dispersions and lipid dispersions containing fusion
inhibitor as the temperature was progressively in-
creased. Images were also recorded in the presence
of a ¢xed p15EK concentration of 1 mol% in order
to evaluate the inhibitors’ ability to prevent the for-
mation of inverted lipid phases. This report describes
the e¡ect of these inhibitors on lipid structural pa-
rameters. Based on the results of this technique, we
relate these structural parameters to a proposed
mechanism of inhibition.
2. Materials and methods
2.1. Sample preparation
FeLV (strain C/Sarma, SWISSPROT acces-
sion number P06752) contains the fusion peptide
p15EK (EPISLTVALMLGGLTVGGIAAGVGTG-
TK), which was synthesised by Albachem (Edin-
burgh, UK). CBZ-D-FFG was obtained from Sigma
(St. Louis, MO). LPC and DOPE-Me were pur-
chased from Avanti Polar Lipids (Alabaster, AL)
and used without further puri¢cation.
MLVs were prepared by rehydrating phospholipid
¢lms as previously described [8]. The bu¡er used was
20 mM PIPES, 1 mM EDTA, 150 mM sodium chlo-
ride and 0.3 mM sodium azide at pH 7.4. All samples
had a low lipid concentration of 100 mM, which is
equivalent to 7.57% (w/v) and ensures an excess
water condition. The lipid dispersions were then sub-
jected to ¢ve freeze^thaw cycles. Repeated freezing
and thawing across the chain-melt temperature en-
sures that the lipid is fully hydrated regardless of
the thermal history of the lipid.
2.2. Temperature-resolved X-ray di¡raction
The X-ray di¡raction experiments were performed
at station 2.1 of the Synchrotron Radiation Source at
Daresbury Laboratory, UK and at the SAXS instru-
ment at Sincrotrone Trieste Elettra, Italy. In both
cases, the X-ray wavelength was 0.154 nm. The speci-
men-to-detector length was approximately 1.5 m. At
Daresbury, the sample holder was a Te£on-lined
brass chamber with mica windows and an external
circulating water bath to control the sample temper-
ature. A thermocouple ¢xed to the sample chamber
monitored the temperature continuously. At Elettra,
each sample was contained in a glass capillary tube,
held in a steel block with electronic (Peltier device)
temperature control. The temperature increased in a
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linear fashion at a rate of 30 K/h, a rate at which
metastable cubic phase is not normally observed in
DOPE-Me. Each frame of data collection lasted for
30 s. The e¡ect of thermal radiation from X-ray
beams of this kind was minimal. Aluminium foils
were added to attenuate the incident beam until no
loss of di¡racted intensity was observed throughout
the duration of a complete temperature scan.
2.3. Data analysis
The raw data were corrected using local programs
at each synchrotron. Corrections for sample thick-
ness and variations in detector response were applied
and background counts were subtracted. Detector
response was determined by measuring a ¢xed
source, 59Fe, overnight both before and after data
collection. Calibration of the x-axis for small-angle
scattering was achieved by using rat-tail collagen as a
standard [17]. This calibration was repeated prior to
the exposure of each new sample. The location and
intensity of each order of di¡raction was given by
¢tting Lorentzian distributions.
3. Results
Fig. 1 shows the variation of lattice repeat distance
d with temperature, broken down into the di¡erent
lipid structural phases: L (lamellar), H (hexagonal)
and Q (cubic). Fig. 2 is a schematic summary of this
phase information, making clearer the phase behav-
iour of the pure lipid control and MLVs containing
p15EK and/or fusion inhibitors, as a function of
temperature.
Lipid polymorphism is generally well understood,
with the possible exception of speci¢c cubic space-
groups, so that although phases should normally be
Fig. 1. Change in lattice basis vector lengths (nm) for all observed phases of DOPE-Me with respect to temperature (‡C) as deter-
mined by time-resolved SAXS performed at station 2.1 of the Synchrotron Radiation Source at Daresbury Laboratory, UK and at
the SAXS instrument at Sincrotrone Trieste Elettra, Italy. (A^C) Pure DOPE-Me (E) ; DOPE-Me, 2 mol% CBZ-D-FFG (a) ; DOPE-
Me, 5 mol% CBZ-D-FFG (O). (D^F) DOPE-Me, 1 mol% p15EK (E) ; DOPE-Me, 1 mol% LPC (a) ; DOPE-Me, 1 mol% p15EK,
1 mol% LPC (O). (G^I) DOPE-Me, 1 mol% p15EK with (E) 2 mol%, (a) 5 mol% and (O) 10 mol% CBZ-D-FFG.
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identi¢ed by assigning an (h,k,l) index to each peak,
even SAXS data with few unique orders of di¡rac-
tion can be unambiguously assigned. Di¡raction
peaks from the lamellar, hexagonal and higher order
cubic potentially overlap each other in the region of
q = 0.9 to 1.1 nm31. However, in those cases where
there was coexistence of lamellar and hexagonal, the
latter could easily be distinguished by its unique k3
Fig. 2. Schematic summary of the phase behaviour of MLVs of DOPE-Me and DOPE-Me with p15EK and/or fusion inhibitors, as a
function of temperature. L (lamellar), H (hexagonal) and Q (cubic). The subscript is I (non-inverted), II (inverted) or ? (unknown).
The assignment is described in the text. Dotted line indicates temperatures at which no structure was observed.
Fig. 3. Width of the ¢rst-order Bragg di¡raction peak of MLVs of DOPE-Me (O) and DOPE-Me with either 2 (E) or 5 (a) mol%
CBZ-D-FFG, as a function of temperature. FW1/eH is the full width of the ¢tted Lorentzians at 1/e (e = 2.718) height.
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re£ection, or a discontinuity in the position of the
¢rst order. Also, the ¢rst orders of lamellar and hex-
agonal are so much stronger than higher order cubic
peaks as to be easily identi¢able.
3.1. DOPE-Me and p15EK
The SAXS data for the pure lipid controls were in
agreement with previously published results [8,18].
An ‘ordered’ transition [19] was observed for the
pure lipid at approximately 60‡C where LK and HII
phases coexist (Fig. 1A,B). The lamellar d-repeat (dL)
tended to increase with temperature due to sample
disorder. The calculated hexagonal d-repeat (dH)
steadily decreased after its formation due to in-
creased hydrocarbon chain splay at higher temper-
atures, which facilitates tighter headgroup packing.
Fig. 1D^F shows the typical mesomorphic behav-
Fig. 4. X-ray di¡raction pro¢les of multilamellar vesicles composed of DOPE-Me plus FeLV fusion peptide (1 mol%) at speci¢c tem-
peratures. The diagram clearly shows the emergence of the (110) peak at 70‡C, which is followed by splitting of the (100) and (200)
re£ections as the hexagonal phase develops.
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iour for DOPE-Me with 1 mol% p15EK. As previ-
ously shown [2,3], p15EK is a potent inducer of in-
verted lipid structures, witnessed by the early onset
of the hexagonal phase as well as two cubic phases.
3.2. CBZ-D-FFG
The structural e¡ects of CBZ-D-FFG on DOPE-
Me phase behaviour are signi¢cant, as seen in Fig.
1A^C. Firstly, adding CBZ-D-FFG increases the la-
mellar repeat dL, to 6.3 nm in the 2 mol% and 6.7 nm
in the 5 mol% samples. Secondly, the peptide causes
premature LK breakdown, at 58‡C and 54‡C in the
2 mol% and 5 mol% samples, respectively (see Fig.
2). After LK decay, no coherent scattering is observed
until higher temperatures. At 68‡C, both strong hex-
agonal and weak cubic phases are observed. The unit
cell size of the hexagonal phase is reduced as a func-
tion of increasing CBZ-D-FFG content. Interestingly,
no di¡raction is observed with the 10 mol% sample
regardless of temperature.
The e¡ect of CBZ-D-FFG on the LK phase was
examined further by analysing the full-width of
the ¢tted Lorentzians at 1/e (e = 2.718) height
(FW1/eH). The FW1/eH value is a useful estimate
of sample disorder [20]. Values for the ¢rst-order
re£ections for MLVs with and without CBZ-D-
FFG are shown in Fig. 3. The LK re£ections become
progressively broader as the concentration of CBZ-
D-FFG increased, indicating that CBZ-D-FFG de-
stabilised the LK phase in a concentration-dependent
manner.
Fig. 1G^I shows the e¡ect of adding 1 mol%
p15eK to MLVs of DOPE-Me with CBZ-D-FFG.
The fusion peptide stabilises isotropic structures at
the expense of hexagonal phase. Two di¡erent cubic
phases were observed for each concentration of
CBZ-D-FFG, although their onset increased with
temperature in a concentration-dependent manner.
The two cubic phases are consistent between the
three di¡erent CBZ-D-FFG concentrations, that is,
the same orders appear with the same ratios. Note
that, in the presence of p15EK, cubic structures were
even observed with the CBZ-D-FFG 10 mol% sam-
ple. The lattice repeat distance (dQ) decreases by ap-
proximately 8 nm between onset and 70‡C. In addi-
tion, the fusion peptide negates the large dL increase
of the 5 mol% CBZ-D-FFG.
3.3. LPC
LPC at 1 mol% had a similar e¡ect on the phase
behaviour of DOPE-Me to 2 mol% CBZ-D-FFG.
The onset of the hexagonal phase was observed at
a comparable temperature although, in the presence
of LPC, the LK phase persists to higher temperatures.
In addition, dL and dQ are similar for both samples.
Fig. 4 is an example of raw data that shows the
transition sequence from lamellar to hexagonal.
Note the appearance of the (110) peak at 70‡C,
which is followed by splitting of the (100) and
(200) re£ections as the hexagonal phase develops.
The largest di¡erence, however, between the two in-
Fig. 5. An illustration of the stalk theory of membrane fusion,
showing the commonly accepted intermediates : opposing bi-
layers (a), stalks (b), hemifusion structure (c) and fusion pore
(d). The ¢gure has been expanded to incorporate the ¢ndings
of this study. The oblique insertion of fusion peptide (e) facili-
tates formation of stalks by lipid disruption. Fusion inhibitors
interfere with an early stage of the fusion pathway (a^d), and/
or the lamellar to hexagonal pathway, by reducing negative cur-
vature (f).
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hibitors is that no cubic phase was observed in the
presence of LPC.
In the presence of 1 mol% p15EK the LK phase
persists until 69‡C, somewhat less than with LPC
alone. However, dL is exactly the same with or with-
out the fusion peptide, 0.2 nm larger than pure
DOPE-Me, and 0.1 nm larger than p15EK alone.
Whereas p15EK lowered the onset of hexagonal
phase for pure lipid, in the presence of LPC, it in-
creases the onset, suggesting that the type of hexag-
onal phase is di¡erent. The most marked di¡erence is
that LPC increases dQ, compared to p15EK alone, by
a dramatic 10 nm. The onset is also at higher temper-
ature.
4. Discussion
The results raise interesting topics for debate with
regard to monolayer curvature (especially in the fu-
sion process) and membrane stability. Fusion theory
has been covered in detail by a number of authors
(e.g., [3,5,21]); Fig. 5a^d illustrates the current think-
ing. Two opposed bilayers are ¢rst brought near to
each other, either through thermal £uctuations or by
the action of fusion proteins. The cis lea£ets of the
opposing bilayers merge to form a so-called stalk
structure. Stalks can then grow in diameter until
the trans lea£ets touch forming a hemifusion struc-
ture, also called a transmembrane contact or TMC.
These structures then can either open into fusion
pores or aggregate to form precursors for the HII
phase. Fusion pores can further aggregate to form
a cubic phase or expand until fusion is complete.
However, the exact location and role of fusion
peptides have yet to be determined in the theoretical
considerations of these idealised lipidic structures.
The data above suggest that p15EK promotes nega-
tive curvature, but how exactly does it do this? Fur-
thermore, even in the absence of an intact hinge
mechanism, such as found in haemagglutinin of in-
£uenza or gp41 of HIV, how do fusion peptides such
as p15EK catalyse the ¢rst step of the whole process,
in which two bilayers are brought together? This is
evidenced by the lowering of the LK^HII transition,
which requires overcoming the repulsive interbilayer
van der Waals forces at a lower thermal energy.
We recently reported unique direct evidence for
the insertion of another fusion peptide into mem-
branes at an oblique angle [22]. This mode of inser-
tion leads naturally to the proposal that a likely con-
sequence is the destabilisation of membrane bilayers
and direct promotion of monolayer mixing [23]. This
is shown diagrammatically in Fig. 5e.
In order to bridge the conceptual gap between ob-
servations of obliquely-inserting peptides and the
membrane fusion, it may help to concentrate less
on the bulk properties of membranes and more on
the molecular events taking place in the phospholip-
ids surrounding individual fusion peptide molecules.
The smooth curves seen in diagrams (e.g., Fig. 5) are
unlikely to be a true representation of monolayers
actually undergoing fusion. Although the overall ef-
fect of fusion peptide insertion may be described as a
net increase in negative curvature (hence the appear-
ance of cubic phases), a closer look is likely to reveal
numerous discontinuities in molecular packing. This,
in part, avoids the problem of the high energy of
stalk formation predicted by current theory [3,21].
In short, there may not be a simple, closed form of
geometry for the fusion intermediates, from which
the free energy can be calculated by the Helfrich
equation [24].
Despite all this, the total phase diagram for our
lipid/fusion peptide/inhibitor system, shown in Fig. 2,
can be related to a mechanism of fusion. The ¢rst
task is to properly identify the types of the non-la-
mellar phases. Due to Babinet’s principle, it is im-
possible for di¡raction techniques to distinguish type
I (oil-in-water) and type II (water-in-oil, or inverted)
structures, making phase identi¢cation di⁄cult.
However, from previous knowledge of lipid polymor-
phism and the e¡ects of LPC and CBZ-D-FFG on
bilayers, we can reason what phases are being in-
duced and their importance in the fusion process.
A well-known characteristic of PE lipids is their
propensity to form inverted HII phases [3,8,25,26].
DOPE-Me is characterised by the methyl group on
the ethanolamine headgroup and the low melting
temperature, highly £uid, oleoyl chains. These mo-
lecular attributes contribute to the relatively stable
lamellar phase of this lipid at biological tempera-
tures, in comparison to most other PE lipids. How-
ever, this should not a¡ect the nature of the lamellar
to hexagonal transition, so we expect this to also be
of type LK^HII.
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The e¡ect of p15EK on MLVs of DOPE-Me is to
lower the lamellar to hexagonal transition and induce
new cubic phases. At this reduced TH there is less
thermal energy available for making stalks than in
the pure lipid. The extra work must therefore come
from disruption of the lipid packing by the peptide
(Fig. 5e). It is reasonable to assume that the hexag-
onal phase is HII, since there is no signi¢cant change
in dH or TH from the pure lipid.
The hexagonal and cubic phases coexist over a
broad temperature range and it is quite possible
that the p15EK does not partition equally between
them. Since the fusion peptide promotes the forma-
tion of cubic phases [8], it is possible that it partitions
preferentially there. It seems to be characteristic of
p15EK to induce two separate cubic phases (see Fig.
1F,I). There is inherent di⁄culty in trying to identify
the speci¢c space group of a cubic phase [27], but
this may not be a major concern. Interestingly,
each of the two phases never varies signi¢cantly in
dQ or TQ. We tentatively assign both phases as being
inverted, or type QII. p15EK belongs to the class of
amphipathic peptides that insert obliquely into la-
mellar bilayers. In the highly curved monolayers of
the cubic phase the nature of the peptide^lipid inter-
action is an open question. Could a cubic phase
maintain its symmetry if the peptide were still
obliquely inserted? Has it dissociated from the mem-
brane completely? Until more is known about spe-
ci¢c molecular interactions in the di¡erent lipid
phases, all that can be said is that the importance
of p15EK in the fusion process is the promotion of
inverted structures.
The characteristic molecular shape of the surfac-
tant LPC causes it to form type I micelles, a property
that has been proposed as the basis of its anti-viral
activity [28]. LPC is miscible with DOPE-Me, and no
phase separation was observed in these SAXS mea-
surements. Conceptually, this system is easier to vis-
ualise with the curvature strain model of membrane
fusion. We might expect the addition of LPC to
counterbalance the curvature energy of pure
DOPE-Me bilayers and form a more stable lamellar
phase at higher temperatures. As expected, LPC re-
tards the LK^HII transition by 4‡C and stabilises the
lamellar for another 15‡C.
Fourier transform infrared studies have shown
that LPC can alter the angle of peptide insertion
into the bilayer, such that an otherwise obliquely-
inserting peptide inserts at an angle perpendicular
to the bilayer surface [29]. If LPC is altering the
orientation of p15EK, then the late, post-cubic, ap-
pearance of a hexagonal phase indicates it might be
of type I. In the presence of LPC, the large radius
(dQ = 20^30 nm) of the cubic indicates that this was
type II. Although LPC prefers type I structures, it
requires them to be much smaller. As we have men-
tioned, molecular interactions such as the insertion
of a large peptide may account for the di⁄culties of
a continuum model of fusion. So, although we can
calculate the induced decrease in curvature strain
from the measured repeat spacings, molecular inter-
actions must play a more signi¢cant role in the entire
process.
The sequence for CBZ-D-FFG is taken from the
conserved N-terminal region of F1 protein of the
paramyxovirus family. It has been shown that
CBZ-D-FFG inhibits fusion of DOPE-Me vesicles
[10] and inhibits the infectivity of several viruses,
including Sendai, SV5 and measles [30]. As shown
in Fig. 2, increasing the concentration of CBZ-D-
FFG causes the breakdown of the lamellar phase
well before the formation of a non-lamellar phase.
For each sample, there was a temperature range
where no di¡raction was observed before the onset
of the hexagonal phase and cubic phase. Fig. 3 shows
the increased sample disorder expressed as the width
of the ¢rst order di¡raction peak. No di¡raction at
all was observed with 10 mol% CBZ-D-FFG, indicat-
ing complete micellisation of the lipid.
The observed increase in dL may be a factor in-
volved in membrane destabilisation by CBZ-D-FFG.
The unit cell size is dependent on two tail-to-tail lipid
molecules and the associated interfacial water mole-
cules. Phenylalanine in membrane proteins is often
associated with the hydrophobic^hydrophilic inter-
face, which would place CBZ-D-FFG at the mem-
brane surface. However, we would then expect to
see a decrease in dL from membrane thinning instead
of the observed increase. Furthermore, CBZ-D-FFG
is not charged so it would not be expected to draw
extra water between the bilayers. Previous studies
have argued that the binding a⁄nity of CBZ-D-
FFG to lipid molecules is enhanced with large pos-
itive curvature [11,13,31]. Therefore, we believe that
CBZ-D-FFG breaks down the MLVs into oil-in-
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water (type I) micelles before transforming into an
HI phase. This argument is supported by the obser-
vation that increasing CBZ-D-FFG content reduces
the unit cell size of both the hexagonal and cubic
phases. Increasing the concentration of CBZ-D-
FFG causes the breakdown of LK into micelles at
progressively lower temperatures until the 10 mol%
sample forms micellar dispersions at room temper-
ature.
The mechanism of bilayer breakdown by CBZ-D-
FFG may be related to its ability to inhibit mem-
brane fusion. The HII phase, favoured by p15EK is
eliminated at all concentrations of CBZ-D-FFG.
However, the cubic phases are similar in dQ and
TQ to that found with just the peptide present, in-
dicating that they might be QII. The SAXS data re-
veal that, at a concentration of 5 mol%, CBZ-D-FFG
causes the coexistence of two lamellar phases. One of
these phases has an increased dL, somewhat similar
to the single lamellar phase seen at the same level of
CBZ-D-FFG, in the absence of peptide. At 10 mol%
no lamellar scattering was again observed, although
the peptide caused the formation of cubic phases of a
similar dQ, but higher TQ. This leads to the sugges-
tion that the inhibitor partitions preferentially into
the larger and/or £atter structures and the peptide
into smaller/negatively curved structures. CBZ-D-
FFG and p15EK appear to compete for lipid bind-
ing. However, the modes with which they interact
with lipid molecules are incompatible with each oth-
er.
A pattern is emerging from the above discussion.
Both fusion inhibitors presented here inhibit inverted
phases in general and the HII phase in particular,
however in contrasting ways. Although we have pre-
sented this analysis in terms of monolayer curvature,
this approach is more useful in the case of LPC. The
addition of LPC to DOPE-Me alters the structural
characteristics of the bilayer to reduce the e⁄ciency
of the fusion peptide. In contrast, the mechanism of
inhibition by CBZ-D-FFG primarily involves pro-
tein^lipid interaction.
Regardless of mechanism, inhibition of fusion
seems to bene¢t from the prevention of HII precur-
sors. One of the earliest precursors is the hemifusion
structure (Fig. 5c), which is the most logical structure
before a fusion pore and ultimately, complete fusion.
If the fusion process were to be arrested at this point
or before (Fig. 5f), neither fusion nor HII phases
could occur. However, cubic phases could still occur
because of the numerous spacegroups available that
do not rely upon these intermediates [32]. This agrees
with the data presented here and opens new avenues
of investigation. We believe that further progress
would be made by determining the location and ori-
entation of the fusion promoters and inhibitors with-
in non-lamellar structures.
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